The maintenance of NK cell phenotypes, together with their higher proportion and a notable increase in IFN-γ secretion, underscores the synergistic efficacy of this therapeutic strategy in fighting pancreatic cancer. This evidence concerns the gene IFNG and pancreatic neoplasm.